Bashan Dror (CIK 1781450) reported 2 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-12-23). Recent activity: Buy PLX (56,000 shares), Buy PLX (195,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-12-23 | Protalix BioTherapeutics, Inc. (PLX) | PRESIDENT AND CEO | Buy | 56,000 | $101,360 |
| 2025-09-04 | Protalix BioTherapeutics, Inc. (PLX) | PRESIDENT AND CEO | Buy | 195,000 | $0 |
Source: SEC Form 4 filings · as of 2025-12-23